Cargando…

Early lymphocyte recovery as a predictor of outcome, including relapse, after hematopoietic stem cell transplantation

BACKGROUND: Despite advances in the treatment of acute leukemia, many patients need to undergo hematopoietic stem cell transplantation. Recent studies show that early lymphocyte recovery may be a predictor of relapse and survival in these patients. OBJECTIVE: To analyze the influence of lymphocyte r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morando, Juliane, Fortier, Sérgio Costa, Pasquini, Ricardo, Zanis Neto, José, Bonfim, Carmem Maria Sales
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545430/ https://www.ncbi.nlm.nih.gov/pubmed/23323067 http://dx.doi.org/10.5581/1516-8484.20120108

Ejemplares similares

Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience
por: Marinho, Daniela Hespanha, et al.
Publicado: (2015)

Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
por: Damlaj, Moussab, et al.
Publicado: (2017)

Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation
por: Getz, Joselito, et al.
Publicado: (2020)

Vitamin D deficiency in children and adolescents submitted to hematopoietic stem cell transplantation
por: Campos, Denise Johnsson, et al.
Publicado: (2014)

Four cases of Chédiak-Higashi syndrome
por: de Azambuja, Ana Paula, et al.
Publicado: (2011)

Late chimerical status after bone marrow transplantation in severe aplastic anemia according to two different preparatory regimens
por: Quiroga, Marcia, et al.
Publicado: (2018)

Body composition of Fanconi anemia patients after hematopoietic stem cell transplantation
por: Silva, Priscilla Peixoto Policarpo da, et al.
Publicado: (2017)

Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia
por: Thakar, Monica S., et al.
Publicado: (2017)

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation
por: Gagelmann, Nico, et al.
Publicado: (2023)

Implication of Early Lymphocyte Recovery after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Leukemia
por: Han, Dong Kyun, et al.
Publicado: (2013)

IN TIME: THE VALUE AND GLOBAL IMPLICATIONSOF NEWBORN SCREENING FORSEVERE COMBINED IMMUNODEFICIENCY
por: Meehan, Cristina, et al.
Publicado: (2018)

X-linked adrenoleukodystrophy: correlation between Loes score and diffusion tensor imaging parameters
por: Ono, Sergio Eiji, et al.
Publicado: (2014)

Autologous Transplantation of Bone Marrow Adult Stem Cells for the Treatment of Idiopathic Dilated Cardiomyopathy
por: Westphal, Ricardo João, et al.
Publicado: (2014)

Cytogenetics in Fanconi Anemia: The Importance of Follow-Up and the Search for New Biomarkers of Genomic Instability
por: Merfort, Lismeri Wuicik, et al.
Publicado: (2022)

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
por: Majhail, Navneet Singh, et al.
Publicado: (2012)

Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents
por: Nabarrete, Juliana Moura, et al.
Publicado: (2021)

Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation
por: Liu, Jiangying, et al.
Publicado: (2015)

Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation
por: Locatelli, Franco, et al.
Publicado: (2017)

Neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio as predictors of survival after heart transplantation
por: Seropian, Ignacio M., et al.
Publicado: (2017)

Passenger Lymphocyte Syndrome and Autoimmune Hypothyroidism Following Hematopoietic Stem Cell Transplantation
por: Noubouossie, Denis F., et al.
Publicado: (2022)

Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: A 7 years follow-up
por: Barth, Anneliese L., et al.
Publicado: (2017)

Role of Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma
por: Carella, Angelo Michele
Publicado: (2012)

The Elephant in The Room: AML Relapse Post Allogeneic Hematopoietic Cell Transplantation
por: Abou Dalle, Iman, et al.
Publicado: (2022)

Post‐hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors
por: Roshandel, Elham, et al.
Publicado: (2022)

Pulmonary function is a strong predictor of 2‐year overall survival and non‐relapse mortality after allogenic hematopoietic cell transplantation
por: Schierbeck, Frederikke, et al.
Publicado: (2022)

Pulmonary complications after hematopoietic stem cell transplantation in children: a functional and tomographic evaluation
por: Chong-Silva, Débora Carla, et al.
Publicado: (2022)

1075. Absolute Lymphocyte Count as a Predictor of Cytomegalovirus (CMV) Infection and Recurrence in Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Reekie, Joanne, et al.
Publicado: (2020)

The activities and regulatory landscape of cellular therapies including hematopoietic cell transplantation in the world
por: Okamoto, Shinichiro, et al.
Publicado: (2022)

Daunorubicin, Cytarabine, and Cladribine Regimen Plus Radiotherapy and Donor Lymphocyte Infusion for Extramedullary Relapse of Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation
por: Sanna, Marco, et al.
Publicado: (2013)

Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
por: Zhao, Peng, et al.
Publicado: (2021)

Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors
por: Liberatore, Carmine, et al.
Publicado: (2022)

CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results
por: Li, Zhihui, et al.
Publicado: (2023)

Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission
por: Lee, Je-Hwan, et al.
Publicado: (2010)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
por: Köhler, Natalie, et al.
Publicado: (2021)

Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation
por: Battipaglia, Giorgia, et al.
Publicado: (2022)

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation
por: Godfrey, James, et al.
Publicado: (2022)

Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013)

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
por: Green, Michael M. B., et al.
Publicado: (2016)

Signal-transducing adaptor protein-2 delays recovery of B-lineage lymphocytes during hematopoietic stress
por: Ichii, Michiko, et al.
Publicado: (2020)

Self-perception of periodontal health status among individuals with Fanconi anemia
por: Perdoncini, Nicole Nichele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2cseg3kepgqokuab1solvqreu0